tradingkey.logo
tradingkey.logo
Search

Stocks Quotes

Stock quotes focus on the U.S. market data, including indices, sectors, and related U.S. equity instruments.
US30
US30
US30
51703.700-0.04%
SPX500
SPX500
US500
7404.300-0.21%
NAS100
NAS100
NAS100
28359.700-0.76%

Distribution

Latest
History
No Data

Sector

View More

Industrial Goods

+2.80%
Lockheed Martin Corp+10.41%
Unusual Machines Inc+9.71%
Rectitude Holdings Ltd+9.24%

Pharmaceuticals & Medical Research

+1.13%
Zhengye Biotechnology Holding Ltd+27.69%
Neuphoria Therapeutics Inc+16.82%
Scisparc Ltd+16.22%

Investment Holding Companies

+1.12%
SUNB.NB+6.96%
Miluna Acquisition Units+6.48%
Inflection Point Acquisition IV Ord Shs Class A+5.70%

Energy - Fossil Fuels

+1.03%
Vivakor Inc+28.22%
Robin Energy Ltd+26.91%
TMD Energy Ltd+18.60%

Utilities

+0.99%
Sunation Energy Inc+10.17%
SolarMax Technology Inc+6.33%
Ge Vernova Inc+4.83%

Healthcare Services & Equipment

+0.91%
Advanced Biomed Inc+36.49%
Novocure Ltd+28.39%
Acme United Corp+13.57%
No.
Name
Price
Change
Chg %
Total Score
Time
Volume
Turnover
Market Cap
Shares
Amplitude
Volume Ratio
52wk High
52wk Low
Dividends
Div Yield
5D
10D
20D
60D
120D
250D
Year to Date
Watchlist
4201
Twelve Seas Investment III Rights Exp 21 Nov 2030
Twelve Seas Investment III Rights Exp 21 Nov 2030
TWLVR
0.160
-0.060
-27.27%
--
23.00
3.00
234.14M
0.00
0.00
0.00
0.480
0.130
0.00
0.00
+82.72%
+22.22%
+10.00%
+56.81%
-11.11%
--
--
4202
OppFi Inc
OppFi Inc
OPFI
8.850
-0.390
-4.22%
6.09
495.60K
2.16M
233.96M
26.44M
3.73
1.20
15.030
7.360
0.00
0.00
-5.75%
-4.43%
+0.57%
-0.45%
-8.95%
-21.33%
-15.39%
4203
A2Z Cust2Mate Solutions Corp
A2Z Cust2Mate Solutions Corp
AZ
5.330
-0.050
-0.93%
6.15
137.96K
551.64K
233.92M
43.89M
3.53
0.88
12.360
4.970
0.00
0.00
-6.33%
-7.94%
-1.30%
-27.68%
-27.58%
-49.86%
-18.13%
4204
Sanara Medtech Inc
Sanara Medtech Inc
SMTI
25.520
-0.020
-0.08%
5.99
172.14K
2.91M
233.89M
9.17M
4.67
2.39
35.950
16.047
0.00
0.00
+0.79%
+6.87%
+11.49%
+34.81%
+21.18%
-0.51%
+9.29%
4205
Meridian Corp
Meridian Corp
MRBK
19.770
-0.100
-0.50%
6.33
72.60K
1.13M
233.81M
11.83M
2.26
0.54
21.670
11.160
0.51
2.60
-4.22%
+1.38%
-0.45%
+2.92%
+4.38%
+34.76%
+12.46%
4206
Fossil Group Inc
Fossil Group Inc
FOSL
3.995
-0.165
-3.97%
6.08
1.16M
2.96M
233.32M
58.40M
3.84
2.40
5.745
1.270
0.00
0.00
-5.11%
-2.08%
-0.87%
-13.71%
+7.39%
+125.71%
+6.25%
4207
SUMA Acquisition Rights Exp 05th Mar 2031
SUMA Acquisition Rights Exp 05th Mar 2031
SUMAR
0.280
0.000
0.00%
--
0.00
0.00
233.29M
--
0.00
0.04
0.280
0.200
0.00
0.00
-6.04%
+7.14%
+3.70%
--
--
--
--
4208
SUMA Acquisition Ord Shs Class A
SUMA Acquisition Ord Shs Class A
SUMA
9.950
-0.040
-0.40%
--
42.00
358.00
233.29M
23.45M
0.00
0.02
9.950
9.830
0.00
0.00
-0.10%
+0.10%
+0.71%
+0.81%
--
--
--
4209
Hackett Group Inc
Hackett Group Inc
HCKT
9.290
-0.140
-1.48%
7.38
461.18K
3.29M
233.11M
25.09M
2.70
1.43
26.090
9.155
0.48
5.16
-10.50%
-6.45%
-11.86%
-27.76%
-49.87%
-59.92%
-52.67%
4210
Zhihu Inc
Zhihu Inc
ZH
3.140
0.000
0.00%
5.96
181.42K
165.46K
233.07M
74.23M
2.17
1.07
5.550
2.570
0.00
0.00
-2.18%
-1.57%
+2.28%
-5.42%
-17.37%
-32.76%
-4.27%
4211
Mereo BioPharma Group PLC
Mereo BioPharma Group PLC
MREO
0.293
-0.005
-1.61%
5.89
694.67K
146.21K
232.97M
795.66M
5.98
1.07
3.050
0.200
0.00
0.00
-9.29%
-9.69%
-3.75%
+4.50%
-33.45%
-83.17%
-29.73%
4212
High Templar Tech American Depositary Shares
High Templar Tech American Depositary Shares
HTT
2.500
-0.020
-0.79%
3.09
346.28K
319.41K
232.96M
93.19M
5.42
1.20
5.080
1.880
0.00
0.00
-4.94%
-4.21%
-20.38%
+2.88%
-16.11%
--
-29.58%
4213
Brooge Energy Ltd
Brooge Energy Ltd
BROG
2.600
0.000
0.00%
--
0.00
0.00
232.93M
89.59M
13.47
1.65
4.780
0.810
0.00
0.00
-2.62%
+36.84%
+47.73%
+103.13%
+91.18%
+172.99%
+65.61%
4214
Galata Acquisition Corp II
Galata Acquisition Corp II
LATA
10.120
-0.005
-0.05%
--
5.01K
50.70K
232.76M
23.00M
0.00
1.31
10.200
9.910
0.00
0.00
+0.10%
+0.10%
+0.20%
+0.90%
+0.45%
--
+1.61%
4215
Helix Acquisition Corp II
Helix Acquisition Corp II
HLXB
9.900
0.000
0.00%
--
0.00
0.00
232.74M
23.51M
4.87
1.58
11.590
8.500
0.00
0.00
+8.20%
-7.74%
-7.61%
--
-7.48%
--
-5.71%
4216
Peoples Bancorp of North Carolina Inc
Peoples Bancorp of North Carolina Inc
PEBK
42.530
-0.290
-0.68%
4.51
84.84K
2.57M
232.19M
5.46M
2.33
1.55
43.310
26.687
0.81
1.90
-2.16%
+1.29%
-3.16%
+8.14%
+18.36%
+45.43%
+18.03%
4217
Insight Digital Partners II
Insight Digital Partners II
DYORU
10.325
+0.175
+1.72%
--
3.00
31.00
231.80M
0.00
0.00
0.00
11.510
10.030
0.00
0.00
+0.49%
+0.00%
+1.73%
+2.53%
+2.43%
--
--
4218
Insight Digital Partners II Ord Shs Class A
Insight Digital Partners II Ord Shs Class A
DYOR
10.070
-0.008
-0.08%
--
53.00
202.00
231.61M
23.00M
0.00
0.00
10.470
9.870
0.00
0.00
+0.10%
+0.10%
+0.20%
+0.80%
+1.10%
--
+1.61%
4219
TrueBlue Inc
TrueBlue Inc
TBI
7.610
-0.740
-8.86%
6.84
235.88K
923.67K
231.18M
30.38M
8.38
0.94
7.780
3.180
0.00
0.00
-7.42%
-5.58%
+14.26%
+60.89%
+54.67%
+3.54%
+67.25%
4220
AG Mortgage Investment Trust Inc
AG Mortgage Investment Trust Inc
MITT
7.260
-0.140
-1.89%
5.79
145.74K
506.55K
230.40M
31.73M
1.68
1.01
9.270
5.625
2.74
37.78
-7.04%
-6.56%
-10.15%
-11.25%
-19.06%
-6.20%
-14.79%
4221
Anavex Life Sciences Corp
Anavex Life Sciences Corp
AVXL
2.485
-0.065
-2.55%
5.66
1.18M
2.13M
230.29M
92.67M
3.72
1.17
13.990
2.610
0.00
0.00
+6.20%
-7.96%
-2.93%
-24.47%
-49.39%
-80.49%
-30.20%
4222
Bluerock Acquisition Units
Bluerock Acquisition Units
BLRKU
10.090
0.000
0.00%
--
0.00
0.00
230.23M
0.00
0.09
3.57
10.990
9.980
0.00
0.00
+0.10%
-0.77%
+0.00%
+0.40%
+0.60%
--
+0.90%
4223
Bluerock Acquisition Class A Ord Shs
Bluerock Acquisition Class A Ord Shs
BLRK
10.040
+0.030
+0.30%
--
6.00
60.00
230.23M
23.00M
0.00
0.01
10.000
9.870
0.00
0.00
+0.20%
+0.30%
+0.50%
+1.21%
--
--
--
4224
RGC Resources Inc
RGC Resources Inc
RGCO
22.120
-0.950
-4.12%
6.00
19.47K
318.56K
230.18M
10.41M
7.95
1.14
24.500
19.680
0.85
3.84
-16.65%
-8.41%
-11.63%
+1.24%
+3.46%
+7.01%
+3.85%
4225
Galectin Therapeutics Inc
Galectin Therapeutics Inc
GALT
3.490
-0.010
-0.29%
4.72
335.76K
873.78K
229.84M
65.86M
5.14
0.79
7.130
1.220
0.00
0.00
-17.40%
-20.14%
-10.97%
+47.26%
+19.11%
+18.71%
-16.11%
4226
SVCC
SVCC
SVCC
10.620
+0.020
+0.19%
--
815.00
6.53K
229.55M
21.61M
0.09
1.11
10.560
10.110
0.00
0.00
+0.09%
+0.38%
+0.85%
+1.34%
+2.12%
+3.61%
+2.46%
4227
Entrada Therapeutics Inc
Entrada Therapeutics Inc
TRDA
6.045
-0.105
-1.71%
6.27
791.91K
3.38M
229.36M
37.94M
7.28
1.67
16.450
4.930
0.00
0.00
-12.01%
-18.31%
-19.83%
-53.36%
-48.16%
-5.40%
-41.20%
4228
Quoin Pharmaceuticals Ltd
Quoin Pharmaceuticals Ltd
QNRX
4.370
-0.005
-0.11%
5.94
9.67K
25.74K
229.17M
52.44M
2.82
1.08
41.800
4.550
0.00
0.00
+5.05%
-6.42%
+14.10%
-19.96%
-47.35%
-48.92%
-69.72%
4229
ACELYRIN Inc
ACELYRIN Inc
SLRN
2.270
0.000
0.00%
--
0.00
0.00
229.06M
100.91M
7.17
2.67
7.250
1.845
0.00
0.00
+8.61%
-6.20%
-2.99%
-12.02%
-51.70%
-50.97%
-27.71%
4230
Black Spade Acquisition III Units
Black Spade Acquisition III Units
BIII_u
10.150
0.000
0.00%
--
0.00
0.00
228.85M
0.00
0.39
23.71
10.190
9.921
0.00
0.00
-0.10%
-0.98%
+0.79%
+1.20%
+1.10%
--
--

Stock Analysis

Intel Q2 Earnings Far Exceed Expectations: 59% Data Center Business Growth, CPUs Becoming AI Era Protagonists Again

TradingKey - As the market continues to question whether Intel (INTC) can truly ride the AI wave, the company’s second-quarter results have provided an answer. After market close on July 23 ET, Intel released its Q2 2026 earnings report, with revenue, earnings, and next-quarter guidance all significantly exceeding Wall Street's previous expectations.

TradingKey24 minutes ago
TradingKey - As the market continues to question whether Intel (INTC) can truly ride the AI wave, the company’s second-quarter results have provided an answer. After market close on July 23 ET, Intel released its Q2 2026 earnings report, with revenue, earnings, and next-quarter guidance all significantly exceeding Wall Street's previous expectations.

NovoCure (NVCR) Breaks Out on Q2 2026 Earnings - Optune Pax Driving Recovery

TradingKey - NovoCure surged to $19.91 after Q2 2026 earnings released this morning. Revenue consensus was $172M growing 8.6% YoY. The story is Optune Pax's FDA approval and multi-indication expansion after June's TRIDENT trial disappointment. Here is the setup.

TradingKey2 hours ago
TradingKey - NovoCure surged to $19.91 after Q2 2026 earnings released this morning. Revenue consensus was $172M growing 8.6% YoY. The story is Optune Pax's FDA approval and multi-indication expansion after June's TRIDENT trial disappointment. Here is the setup.

Micron (MU) Hits $1,000 on Three Catalysts - Google Capex, Vera Rubin, NAND Shortage

TradingKey - Micron rose 4% to $1,000 on Thursday driven by Google and Tesla's massive AI capex confirming memory demand, Nvidia's Vera Rubin boosting HBM requirements, and TrendForce flagging a NAND shortage. At $996, $992 resistance has been cleared.

TradingKey3 hours ago
TradingKey - Micron rose 4% to $1,000 on Thursday driven by Google and Tesla's massive AI capex confirming memory demand, Nvidia's Vera Rubin boosting HBM requirements, and TrendForce flagging a NAND shortage. At $996, $992 resistance has been cleared.

Japan and South Korea Stocks Open Lower, KOSPI Drops Over 3%, SoftBank Falls Over 5%, SK Hynix and Kioxia Fall Nearly 4%

TradingKey - In early Asian trading on July 24, Japanese and South Korean stock markets opened lower and continued to decline. Influenced by the sharp overnight pullback in US stocks and escalating geopolitical risks in the Middle East, market risk-off sentiment has risen markedly.

TradingKey3 hours ago
TradingKey - In early Asian trading on July 24, Japanese and South Korean stock markets opened lower and continued to decline. Influenced by the sharp overnight pullback in US stocks and escalating geopolitical risks in the Middle East, market risk-off sentiment has risen markedly.

Today’s Market Recap: Oil Breaks $100, Fueling Inflation Fears, as AI Capex Faces Scrutiny and Tesla’s 14% Plunge Drags Down Tech Sector

TradingKey - The market was hit by a double whammy of soaring oil prices and doubts about the return on AI investments sparked by increased capital expenditures at Google(GOOGL) and Tesla(TSLA). The three major U.S. stock indices plummeted. At the close, the Dow Jones Industrial Average fell 0.97% t

TradingKey3 hours ago
TradingKey - The market was hit by a double whammy of soaring oil prices and doubts about the return on AI investments sparked by increased capital expenditures at Google(GOOGL) and Tesla(TSLA). The three major U.S. stock indices plummeted. At the close, the Dow Jones Industrial Average fell 0.97% t

Intel Q2 Net Profit Swings to Profit YoY, Adjusted EPS Doubles Estimates: Revenue Up 25%, After-Hours Shares Rise Over 13%

Intel (INTC) released its second-quarter 2026 financial results after the U.S. market close on July 23, Eastern Time. As of press time, the stock rose 12.44% to $112.7. During the period, Intel's revenue increased by 25% year-on-year to $16.128 billion, significantly exceeding the market expectation of $14.42 billion by approximately 12%. CEO Lip-Bu Tan stated that this marked the company's strongest quarterly revenue growth in over fifteen years, driven by increased speed, stronger execution, and customer focus.

TradingKey7 hours ago
Intel (INTC) released its second-quarter 2026 financial results after the U.S. market close on July 23, Eastern Time. As of press time, the stock rose 12.44% to $112.7. During the period, Intel's revenue increased by 25% year-on-year to $16.128 billion, significantly exceeding the market expectation of $14.42 billion by approximately 12%. CEO Lip-Bu Tan stated that this marked the company's strongest quarterly revenue growth in over fifteen years, driven by increased speed, stronger execution, and customer focus.

TradingKey SmartPicks

Upcoming Events

Earnings

Dividends

Stock Splits

IPO

Market Heatmap

Stocks

Sector

tradingkey.logo
* References, analysis, and trading strategies are provided by the third-party provider, Trading Central, and the point of view is based on the independent assessment and judgement of the analyst, without considering the investment objectives and financial situation of the investors.
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.